Blood Bank of Delmarva competitors

Healthcare leader with broad experience across multi-site health service operations, laboratories, and life sciences. Early career as a physician, then McKinsey management consultant, followed by two decade career in healthcare general management, most recently CEO for high growth Laboratory Services company. Expertise in multi-site outpatient and physician management, leveraging Health IT, M&A and achieving revenue and profit growth under challenging reimbursement conditions with a passion for building high performing teams that achieve results.

Brian Gannon is a President/CEO at Gulf Coast Regional Blood Center. He works or has worked as President/CEO at Blood Center/The. Brian attended University of Louisiana at Lafayette.

Michael Parejko is a Chief Executive Officer - Mississippi Valley Regional Blood Center at Mississippi Valley Regional Blood Center and is based in Davenport, Iowa. He has worked as COO/ EVP Indiana Blood Center at Indiana Blood Center, Medical Technologist at Northwestern Memorial Hospital, and Director of US Sales- Eastern Region at Pall Corporation. Michael works or has worked as Board Member at United Way of the Quad Cities Area. He studied at Indiana Wesleyan University between 2005 and 2007 and NMU between 1983 and 1988.

Christopher D. Hillyer, MD, President and CEO and Chief Scientific Officer of New York Blood Center (NYBC), and Professor, Department of Medicine, Weill Cornell Medical College, was previously the endowed Distinguished Service Professor, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, where he served as director of the Emory Center for Transfusion and Cellular Therapies. He is board certified in transfusion medicine, hematology, medical oncology and internal medicine. He is an editor of 12 textbooks including the 16-18th editions of the AABB Technical Manual, and is recognized internationally as an expert in hematology, blood transfusion, and cellular therapies. His book, Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects, has become a primary resource throughout the world. Dr. Hillyer has authored more than 175 articles pertaining to transfusion, stem cells, erythropoiesis, and virology, and has been awarded millions of dollars in research funding from the National Institutes of Health, the CDC, and other agencies. He is a past-president of AABB, a former trustee of the National Blood Foundation, and served as an associate editor of TRANSFUSION.He is the 2014 Emily Cooley Award recipient for his “significant commitment and contributions to the field of transfusion medicine..." and was recognized with two Tiffany Awards from the American Red Cross for his work in Africa. Dr. Hillyer is an architect of NYBC Ventures, co-founder of Transfusion & Transplantation Technologies, Inc. (3Ti), HemeXcel Purchasing Alliance, and HemeXcel Resources, and holds a number of patents related to blood banking and cellular therapies. He has served on a number of for-profit and not-for-profit boards.Dr. Hillyer received his BS from Trinity College with Honors and his MD from the University of Rochester School of Medicine, with postgraduate fellowships in hematology-oncology, transfusion medicine and bone marrow transplantation at Tufts-New England Medical Center in Boston.

Nancy Eckert works at Lifesouth Community Blood Center and a CEO at Lifesouth Community Blood Center and is based in Gainesville, Florida. She attended University of Florida.

JB Gaskins is a Chief Executive Officer at Blood Assurance Inc and is based in Chattanooga, Tennessee. He has worked as Trainer at Pro Health and Fitness, Melboourne, FL; G3 OPS - 143d Sustainment Command Expeditionary at US Army; and Exectutive Director at United Blood Services, Fargo. Jb studied at Eastern Florida State College between 1977 and 1979, Saint Leo University between 1992 and 2003, and University of Florida between 1979 and 1980.